Cilta-Cel Provides Deep MRD Negativity in Lenalidomide-Refractory Multiple Myeloma

Published: 02/15/2025

Cilta-Cel Provides Deep MRD Negativity in Lenalidomide-Refractory Multiple Myeloma

tags

Latest News

NEWS 02.12.2026

Pandorum Tech raises $18M to expand operations for bioengineered cornea – Eyes On Eyecare

NEWS 02.12.2026

Tanzania’s medical tourism agenda gets major boost with KCMC’s steam surgery – MSN

NEWS 02.12.2026

Ocugen Appoints New Finance Chief to Steer Gene Therapy Pipeline Toward Approval – AD HOC NEWS

NEWS 02.12.2026

beyondMD Expands Telehealth Regenerative Medicine with BPC‑157 fo – The National Law Review